<?xml version="1.0" encoding="UTF-8"?>
<results title="tropicalVirus">
 <result pre="combat emerging infectious diseases? Lessons from the case of a" exact="Zika" post="virus human challenge trial PalaciosRicardoricardo.palacios@butantan.gov.br12ShahSeema K.SeShah@luriechildrens.org34[1], 0000 0001 1702"/>
 <result pre="part of epidemic preparedness, we use the case of a" exact="Zika" post="virus HCT to explore whether and when HCTs might"/>
 <result pre="acceptable. Keywords Human challenge trials Research ethics Ethics in emergencies" exact="Zika" post="virus Global Forum on Bioethics in Research GFBRBangkok, Thailand28-29"/>
 <result pre="virus, MERS-CoV, Lassa virus, Ebola virus disease, Marburg virus disease," exact="Zika" post="virus, and Rift Valley Fever [8]. These are serious"/>
 <result pre="currently unknown to cause human disease�? [8]. Notably, in 2013," exact="Zika" post="virus was a pathogen thought to cause only mild"/>
 <result pre="epidemic. In this paper, we consider the case of a" exact="Zika" post="virus HCT as a springboard to determine whether and"/>
 <result pre="might be useful in this scenario. The case of a" exact="Zika" post="virus HCT In 2015, Zika virus emerged as a"/>
 <result pre="scenario. The case of a Zika virus HCT In 2015," exact="Zika" post="virus emerged as a major public health crisis in"/>
 <result pre="countries. Although the WHO declared the state of emergency surrounding" exact="Zika" post="virus over in November 2016, it indicated that Zika"/>
 <result pre="surrounding Zika virus over in November 2016, it indicated that" exact="Zika" post="is likely to be a persistent and unpredictable public"/>
 <result pre="threat for years to come [9]. Some estimates indicate that" exact="Zika" post="virus is asymptomatic in the vast majority of people"/>
 <result pre="transient, but it can have potentially devastating consequences. In adults," exact="Zika" post="virus can cause neurological complications, including but not limited"/>
 <result pre="evidence is needed [12]. Perhaps of greatest concern, transmission of" exact="Zika" post="virus from a pregnant woman to a fetus can"/>
 <result pre="from a pregnant woman to a fetus can cause congenital" exact="Zika" post="syndrome. Congenital Zika syndrome typically involves microcephaly and potentially"/>
 <result pre="woman to a fetus can cause congenital Zika syndrome. Congenital" exact="Zika" post="syndrome typically involves microcephaly and potentially significant abnormalities in"/>
 <result pre="development, visual impairment, cardiac defects, and other complications [13, 14]." exact="Zika" post="virus is known to be transmissible through mosquito vectors,"/>
 <result pre="ways [15, 16]. Until recently, the duration of infectivity for" exact="Zika" post="virus was highly uncertain but is now thought to"/>
 <result pre="HCT in which healthy volunteers would be intentionally exposed to" exact="Zika" post="virus, which was a newly emerging public health threat"/>
 <result pre="publicly available, some of the details are widely known. The" exact="Zika" post="virus HCT was proposed to learn more about the"/>
 <result pre="was proposed to learn more about the early stages of" exact="Zika" post="infection and efficiently test whether vaccines can protect against"/>
 <result pre="Zika infection and efficiently test whether vaccines can protect against" exact="Zika" post="infection. The trial was to be conducted in the"/>
 <result pre="enroll healthy volunteers who would not otherwise be exposed to" exact="Zika" post="virus. Previous exposure to other viruses in the same"/>
 <result pre="the Walter Reed Army Institute of Research were concerned that" exact="Zika" post="virus HCTs were ethically complex. They therefore assembled an"/>
 <result pre="multidisciplinary expert panel to address the question of whether a" exact="Zika" post="virus HCT could be ethically justified, and if so,"/>
 <result pre="with making recommendations to NIH about the ethical considerations for" exact="Zika" post="HCTs in general. Unlike standard ethics review committee or"/>
 <result pre="the panel considered the latest scientific and epidemiological information about" exact="Zika" post="virus, existing ethical frameworks for HCTs, and ongoing research"/>
 <result pre="virus, existing ethical frameworks for HCTs, and ongoing research into" exact="Zika" post="vaccines. The panel held several teleconferences and one in-person"/>
 <result pre="drafted a report that was released in February 2017. The" exact="Zika" post="HCT ethics expert panel offered a preliminary ethical framework"/>
 <result pre="HCT ethics expert panel offered a preliminary ethical framework for" exact="Zika" post="HCTs and concluded that Zika virus HCTs could be"/>
 <result pre="a preliminary ethical framework for Zika HCTs and concluded that" exact="Zika" post="virus HCTs could be ethically justified in principle but"/>
 <result pre="[18]. The two main reasons that the panel concluded a" exact="Zika" post="HCT would be premature were that: (1) there was"/>
 <result pre="their consent to participation and not enough was known about" exact="Zika" post="transmission to ensure they could be protected; and (2)"/>
 <result pre="ongoing and the panel could not be confident that a" exact="Zika" post="HCT was needed to accelerate the course of vaccine"/>
 <result pre="needed to accelerate the course of vaccine development. First, although" exact="Zika" post="virus appears to be asymptomatic for most of those"/>
 <result pre="ongoing research, it was unclear at the time whether a" exact="Zika" post="HCT offered sufficient potential for societal benefit to justify"/>
 <result pre="Although these were the most critical and unresolved issues facing" exact="Zika" post="HCTs at the time, the panel also noted several"/>
 <result pre="research-related injury, and consultation with the community in which a" exact="Zika" post="HCT would be conducted—considerations which may be helpful for"/>
 <result pre="important to note that external conditions, the evidence available about" exact="Zika" post="virus, and the epidemiology of Zika virus have changed"/>
 <result pre="the evidence available about Zika virus, and the epidemiology of" exact="Zika" post="virus have changed since the panel submitted its recommendations."/>
 <result pre="its recommendations. The period of infectivity for those infected with" exact="Zika" post="virus is much better known; Zika virus can be"/>
 <result pre="for those infected with Zika virus is much better known;" exact="Zika" post="virus can be transmitted for roughly 30 days in individuals"/>
 <result pre="avoid unprotected sexual activity) [20]. Additionally, although a phase II" exact="Zika" post="vaccine trial is ongoing, enrollment is lower than projected,"/>
 <result pre="and some drug and vaccine developers have halted research on" exact="Zika" post="virus [21]. This suggests that a Zika HCT could"/>
 <result pre="halted research on Zika virus [21]. This suggests that a" exact="Zika" post="HCT could have clear and considerable value if conducted"/>
 <result pre="plan to protect bystanders and research participants. Application of the" exact="Zika" post="HCT case to other HCTs on emerging infectious diseases"/>
 <result pre="examination of the two major issues that arose in the" exact="Zika" post="HCT ethics consultation provides lessons for other potential HCTs"/>
 <result pre="in the United States. First, as was the case with" exact="Zika" post="virus, many stakeholders are likely to be interested in"/>
 <result pre="difficult to conduct giving the declining numbers and unpredictability of" exact="Zika" post="outbreaks, and the initial uncertainty about the value of"/>
 <result pre="outbreaks, and the initial uncertainty about the value of a" exact="Zika" post="HCT was resolved [17]. One possibility, then, is that"/>
 <result pre="uncertainty. For example, the modes and duration of transmission of" exact="Zika" post="virus were not known at the time of the"/>
 <result pre="at the time of the review of the ethics of" exact="Zika" post="HCTs, so the risks of transmission to people outside"/>
 <result pre="determine, let alone mitigate. As has been described elsewhere, the" exact="Zika" post="HCT ethics panel struggled with the question of how"/>
 <result pre="give consent to being exposed to risk of infection with" exact="Zika" post="virus, and there is limited guidance on how to"/>
 <result pre="will also have to be weighed in the balance. Although" exact="Zika" post="virus is asymptomatic in roughly half to three-quarters of"/>
 <result pre="were satisfied as well). Application to a &quot;Disease X�? Although" exact="Zika" post="virus was discovered in Uganda in 1947, it did"/>
 <result pre="concern until relatively recently. In 1956, Bearcroft inoculated himself with" exact="Zika" post="virus and noted only very mild, transient symptoms [32]."/>
 <result pre="[33], as seems to have occurred in recent years with" exact="Zika" post="virus. Recognizing that the world was not prepared for"/>
 <result pre="that the world was not prepared for the most recent" exact="Zika" post="epidemic, preparedness for the next &quot;Disease X�? is critically"/>
 <result pre="in an endemic setting. As with the example of the" exact="Zika" post="HCT, there are several other issues that should be"/>
 <result pre="public health emergency is overwhelming. The number of articles on" exact="Zika" post="virus registered in the National Center for Biotechnology Information’s"/>
 <result pre="more targeted fashion. Conclusion Examining the case of a potential" exact="Zika" post="virus HCT reveals that HCTs on emerging infectious diseases"/>
 <result pre="Authors’ information Both authors were not involved in any proposed" exact="Zika" post="virus human challenge trials as investigators or part of"/>
 <result pre="independent reviewers serving on a panel evaluating the ethics of" exact="Zika" post="virus human challenge trials. Funding Funds were provided by"/>
 <result pre="The authors participated in the independent panel that reviewed the" exact="Zika" post="virus human challenge trial but have no competing interests."/>
 <result pre="the International Health Regulations regarding microcephaly, other neurological disorders and" exact="Zika" post="virus (18 November 2016)2016GenevaWHO 10.MuñozLSBarrerasPPardoCAZika Virus-Associated Neurological Disease in"/>
 <result pre="Encephalitis, and MyelitisSemin Reprod Med201634527327910.1055/s-0036-159206627612158 11.ParraBLizarazoJJiménez-ArangoJAZea-VeraAFGonzález-ManriqueGVargasJet al.Guillain-Barre Syndrome Associated with" exact="Zika" post="Virus Infection in ColombiaN Engl J Med2016375161513152310.1056/NEJMoa160556427705091 12.AlettiMLecoulesSKanczugaVSolerCMaquartMSimonFet al.Transient"/>
 <result pre="ColombiaN Engl J Med2016375161513152310.1056/NEJMoa160556427705091 12.AlettiMLecoulesSKanczugaVSolerCMaquartMSimonFet al.Transient myocarditis associated with acute" exact="Zika" post="virus infectionClin Infect Dis201764567867927940942 13.de AraújoTVBRodriguesLCde Alencar XimenesRAde BarrosM-FDMontarroyosURde"/>
 <result pre="Professor Fernando Figueira; State Health Department of Pernambuco. Association between" exact="Zika" post="virus infection and microcephaly in Brazil, January to May,"/>
 <result pre="Infect Dis201616121356136310.1016/S1473-3099(16)30318-827641777 14.MooreCAStaplesJEDobynsWBPessoaAVenturaCVFonsecaEBet al.Characterizing the Pattern of Anomalies in Congenital" exact="Zika" post="Syndrome for Pediatric CliniciansJAMA Pediatr2017171328829510.1001/jamapediatrics.2016.398227812690 15.TurmelJMAbgueguenPHubertBVandammeYMMaquartMLe Guillou-GuillemetteHet al.Late sexual"/>
 <result pre="for Pediatric CliniciansJAMA Pediatr2017171328829510.1001/jamapediatrics.2016.398227812690 15.TurmelJMAbgueguenPHubertBVandammeYMMaquartMLe Guillou-GuillemetteHet al.Late sexual transmission of" exact="Zika" post="virus related to persistence in the semenLancet.201638710037250110.1016/S0140-6736(16)30775-927287833 16.SwaminathanSSchlabergRLewisJHansonKECouturierMRFatal Zika"/>
 <result pre="of Zika virus related to persistence in the semenLancet.201638710037250110.1016/S0140-6736(16)30775-927287833 16.SwaminathanSSchlabergRLewisJHansonKECouturierMRFatal" exact="Zika" post="Virus Infection with Secondary Nonsexual TransmissionN Engl J Med2016375191907190910.1056/NEJMc161061327681699"/>
 <result pre="Secondary Nonsexual TransmissionN Engl J Med2016375191907190910.1056/NEJMc161061327681699 17.Cohen, J. As massive" exact="Zika" post="vaccine trial struggles, researchers revive plan to intentionally infect"/>
 <result pre="HF, McCutchan F, Miller F, et al. Ethical considerations for" exact="Zika" post="virus human challenge trials. NIH. https://www.niaid.nih.gov/sites/default/files/EthicsZikaHumanChallengeStudiesReport2017.pdf. Accessed 15 Jun"/>
 <result pre="NIH. https://www.niaid.nih.gov/sites/default/files/EthicsZikaHumanChallengeStudiesReport2017.pdf. Accessed 15 Jun 2018. 19.CounotteMJKimCRWangJet al.Sexual transmission of" exact="Zika" post="virus and other flaviviruses: A living systematic reviewPLoS Med2018157e100261110.1371/journal.pmed.100261130040845"/>
 <result pre="Guidance for Preconception Counseling and Prevention of Sexual Transmission of" exact="Zika" post="Virus for Persons with Possible Zika Virus Exposure -"/>
 <result pre="of Sexual Transmission of Zika Virus for Persons with Possible" exact="Zika" post="Virus Exposure - United States, September 2016MMWR Morb Mortal"/>
 <result pre="WHO/NIH meeting report on approaches to development and licensure of" exact="Zika" post="vaccine candidatesVaccine.201937686386810.1016/j.vaccine.2018.12.04030639461 22.ShahSKKimmelmanJLyerlyADLynchHFMillerFGPalaciosRet al.Bystander risk, social value, and ethics"/>
 <result pre="research risksJ Med Ethics200935744544910.1136/jme.2008.02606219567696 31.MitchellPKMier-Y-Teran-RomeroLBiggerstaffBJet al.Reassessing Serosurvey-Based Estimates of the" exact="Zika" post="Symptomatic ProportionAm J Epidemiol201918820321310.1093/aje/kwy189 32.HoneinMADawsonALPetersonEEet al.Birth Defects Among Fetuses"/>
 <result pre="Fetuses and Infants of US Women with Evidence of Possible" exact="Zika" post="Virus Infection During PregnancyJAMA.20173171596810.1001/jama.2016.1900627960197 33.BearcroftWGZika virus infection experimentally induced"/>
</results>
